Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | PRKCA | P17252 | 7/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | NOS3 | P29474 | 1/20 | 0.37 |
| ▸ | NOS1 | P29475 | 1/20 | 0.37 |
| ▸ | NOS2 | P35228 | 1/20 | 0.37 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9172090 | 1.00 | SMN1; SMN2 (0.43) | SMN1; SMN2PRKCACYP1A2NOS3NOS1 | |
| SCHEMBL9171420 | 1.00 | SMN1; SMN2 (0.43) | SMN1; SMN2PRKCACYP1A2NOS3NOS1 | |
| SCHEMBL7178100 | 1.00 | SMN1; SMN2 (0.43) | SMN1; SMN2PRKCACYP1A2NOS3NOS1 | |
| SCHEMBL7187580 | 1.00 | SMN1; SMN2 (0.43) | SMN1; SMN2PRKCACYP1A2NOS3NOS1 | |
| SCHEMBL14994441 | 1.00 | SMN1; SMN2 (0.43) | SMN1; SMN2PRKCACYP1A2NOS3NOS1 | |
| SCHEMBL7180354 | 1.00 | SMN1; SMN2 (0.43) | SMN1; SMN2PRKCACYP1A2NOS3NOS1 | |
| SCHEMBL9171097 | 1.00 | SMN1; SMN2 (0.43) | SMN1; SMN2PRKCACYP1A2NOS3NOS1 | |
| SCHEMBL30754370 | 0.94 | CYP1A2 (0.47) | SMN1; SMN2PRKCACYP1A2PPARG | |
| SCHEMBL2146282 | 0.94 | CYP1A2 (0.47) | SMN1; SMN2PRKCACYP1A2PPARG | |
| SCHEMBL2512382 | 0.92 | CYP1A2 (0.50) | PRKCACYP1A2PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1928 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739734-A1 | PROCESS FOR THE MANUFACTURE OF THERMOSET POLYESTER FOAMS | Saint-Gobain Isover (FR) | 2026-05-13 | — | — | EP | claimed |
| EP-4461797-B1 | WHOLE-WHEAT BARREL-AGED STRONG LAGER BEER AND PREPARATION PROCESS THEREFOR | TSINGTAO BREWERY CO LTD (CN) | 2026-04-08 | — | — | EP | claimed |
| US-12575585-B2 | Crumb chocolate flavor compositions | MARS, INCORPORATED (US) | 2026-03-17 | — | — | US | claimed |
| US-20250352444-A1 | Antimicrobial mixtures | SYMRISE AG (DE) | 2025-11-20 | — | — | US | claimed |
| US-20250344991-A1 | COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION | UNIV ROCKEFELLER (US) | 2025-11-13 | — | — | US | claimed |
| US-12460155-B2 | Sugar/gluconoamide alkoxylate compositions and uses thereof | ECOLAB USA INC. (US) | 2025-11-04 | — | — | US | claimed |
| EP-4635407-A2 | COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION | The Rockefeller University (US) | 2025-10-22 | — | — | EP | claimed |
| EP-3648613-B1 | COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION | UNIV ROCKEFELLER (US) | 2025-09-24 | — | — | EP | claimed |
| EP-3466281-B1 | TOBACCO SMOKE FILTER | FILTRONA PTE LTD (SG) | 2025-08-13 | — | — | EP | claimed |
| US-20250235136-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-07-24 | — | — | US | claimed |
| EP-1716159-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | General Electronic Company (US) | 2006-11-02 | — | — | EP | claimed |
| US-7105628-B2 | Compositions for golf equipment | ACUSHNET COMPANY (US) | 2006-09-12 | — | — | US | claimed |
| EP-1697386-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | General Electric Company A Corporation of the State of New York (US) | 2006-09-06 | — | — | EP | claimed |
| WO-2006052985-A1 | LACTONES AS NEW OXYGENATE FUEL ADDITIVES, FUELS BASED THEREON AND METHODS FOR USING SAME | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2006-05-18 | — | — | WO | claimed |
| US-20060096158-A1 | Lactones as new oxygenate fuel additives, fuels based thereon and methods for using same | ROBINSON J M | 2006-05-11 | — | — | US | claimed |
| WO-2005066187-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| WO-2005066186-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20040220378-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250352444-A1 | Antimicrobial mixtures | LRBA, MGLL, TAS2R50 | SMN1; SMN2 2240/4885PRKCA 4130/4885CYP1A2 3031/4885 |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | F9, RPL39, ECPAS | SMN1; SMN2 769/4885PRKCA 3726/4885CYP1A2 1721/4885 |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | F9, RPL39, ALDH16A1 | SMN1; SMN2 692/4885PRKCA 3688/4885CYP1A2 1826/4885 |
| US-12575585-B2 | Crumb chocolate flavor compositions | DAGLA, MSMO1, HSD3B2 | SMN1; SMN2 2508/4885PRKCA 580/4885CYP1A2 1633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.